Cargando…

Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives

Huntington’s disease (HD) is an autosomal dominant progressive brain disorder, caused by a pathological expansion of a CAG repeat that encodes the huntingtin gene. This genetic neurodegenerative rare disease is characterized by cognitive, motor, and neuropsychiatric manifestations. The aim of the tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-González, Xandra, Cubo, Esther, Simón-Vicente, Lucía, Mariscal, Natividad, Alcaraz, Raquel, Aguado, Laura, Rivadeneyra-Posadas, Jéssica, Sanz-Solas, Antonio, Saiz-Rodríguez, Miriam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056055/ https://www.ncbi.nlm.nih.gov/pubmed/36983567 http://dx.doi.org/10.3390/jpm13030385

Ejemplares similares

Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives
por: Sanz-Solas, Antonio, et al.
Publicado: (2023)

Accelerometer Cut-Points for Physical Activity Assessment in Adults with Mild to Moderate Huntington’s Disease: A Cross-Sectional Multicentre Study
por: Simón-Vicente, Lucía, et al.
Publicado: (2022)

Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives
por: Pinto-Merino, Álvaro, et al.
Publicado: (2022)

Association Between Insulin‐Like Growth Factor‐1 and Social Cognition in Huntington's Disease
por: Gil‐Polo, Cecilia, et al.
Publicado: (2022)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives
por: Cubo, Esther, et al.
Publicado: (2022)

Pharmacogenetics: The future medicine
por: Saini, Rajiv, et al.
Publicado: (2010)

Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives
por: Coyle, Patricia K.
Publicado: (2017)

Pharmacogenetics of alcohol addiction: current perspectives
por: Zastrozhin, M S, et al.
Publicado: (2019)

Pharmacogenetics and Depression: A Critical Perspective
por: Corponi, Filippo, et al.
Publicado: (2019)

Pharmacogenetics of Pediatric Asthma: Current Perspectives
por: Perez-Garcia, Javier, et al.
Publicado: (2020)

A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps
por: Eken, Eda, et al.
Publicado: (2023)

Pharmacogenetic testing in oncology: a Brazilian perspective
por: Suarez-Kurtz, Guilherme
Publicado: (2018)

Análisis del factor influencia familiar e información profesiográfica en la elección vocacional de los estudiantes de la carrera de pedagogía. Período: 86-87 Zona: Xalapa
por: Vicente Rivadeneyra, Lucía
Publicado: (1987)

Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics
por: Chua, E. W., et al.
Publicado: (2012)

From pharmacogenetics to pharmaco-omics: Milestones and future directions
por: Auwerx, Chiara, et al.
Publicado: (2022)

Global Perspective on Telemedicine for Parkinson’s Disease
por: Shalash, Ali, et al.
Publicado: (2021)

Important Pharmacogenetic Information for Drugs Prescribed During the SARS‐CoV‐2 Infection (COVID‐19)
por: Zubiaur, Pablo, et al.
Publicado: (2020)

Huntington's Disease: An Immune Perspective
por: Nayak, Annapurna, et al.
Publicado: (2011)

Future perspectives of prostate cancer therapy
por: Gururajan, Murali, et al.
Publicado: (2012)

Perspectives from the Society for Pediatric Research: Pharmacogenetics for Pediatricians
por: Tang Girdwood, Sonya C., et al.
Publicado: (2022)

Editorial: Precision psychiatry from a pharmacogenetics perspective
por: Brown, Lisa C., et al.
Publicado: (2023)

PriME-PGx: La Princesa University Hospital Multidisciplinary Initiative for the Implementation of Pharmacogenetics
por: Zubiaur, Pablo, et al.
Publicado: (2021)

Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2021)

Novel targets for Huntington’s disease: future prospects
por: Mason, Sarah L, et al.
Publicado: (2016)

Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective
por: Rigter, Tessel, et al.
Publicado: (2020)

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2018)

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
por: Gómez-Aguado, Itziar, et al.
Publicado: (2020)

Cancer pharmacogenetics
por: Marsh, S, et al.
Publicado: (2004)

Experimental Pharmacogenetics
por: Lubs, Herbert A.
Publicado: (1964)

Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010)

Pharmacogenetics of osteoporosis
por: Marini, Francesca, et al.
Publicado: (2010)

The pharmacogenetics of imatinib
por: Dulucq, Stéphanie, et al.
Publicado: (2010)

Pharmacogenetics of Antidepressants
por: Crisafulli, Concetta, et al.
Publicado: (2011)

Pharmacogenetics in the clinic
por: Guchelaar, H.-J.
Publicado: (2013)

Pharmacogenetics of Cannabinoids
por: Hryhorowicz, Szymon, et al.
Publicado: (2017)

Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019)

Pharmacogenetics in Primary Headache Disorders
por: Belyaeva, Irina I., et al.
Publicado: (2022)

Current and Possible Future Therapeutic Options for Huntington’s Disease
por: Ferguson, Mackenzie W., et al.
Publicado: (2022)

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
por: Ovejero-Benito, María C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ctk328d82depvbdt394fro9lnh